v3.20.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2020
INCOME TAXES  
Schedule of component of income tax provision reflected in the consolidated statements of operations

Year Ended

(In millions)

    

December 31, 2020

    

December 31, 2019

    

December 31, 2018

 

Current:

Federal

$

0.1

$

(0.1)

$

(0.5)

Foreign

 

(0.1)

 

8.4

 

5.0

State

 

(4.1)

 

2.9

 

15.5

Total current

 

(4.1)

 

11.2

 

20.0

Deferred:

Federal

 

2.7

 

(4.2)

 

0.8

Foreign

 

57.6

 

(42.8)

 

(7.5)

State

 

3.7

 

13.3

 

0.3

Total deferred

 

64.0

 

(33.7)

 

(6.4)

Total provision (benefit)

$

59.9

$

(22.5)

$

13.6

Schedule of pre-tax income (losses)

Year Ended

(In millions)

    

December 31, 2020

    

December 31, 2019

    

December 31, 2018

 

Domestic

$

(3,036.4)

$

(165.1)

$

154.4

Foreign

 

(1,493.1)

 

(6.5)

 

(30.7)

Total

$

(4,529.5)

$

(171.6)

$

123.7

Schedule of the difference between the effective tax rate on earnings (loss) from continuing operations before income taxes and the U.S. federal income tax statutory rate

Year Ended

(In millions)

    

December 31, 2020

    

December 31, 2019

    

December 31, 2018

 

Income tax expense (benefit) at the federal statutory rate

$

(951.2)

$

(36.0)

$

26.0

Effect of:

State income taxes

 

(89.5)

 

(7.2)

 

8.9

Increase in reserve for uncertain tax positions

 

(1.9)

 

8.4

 

5.2

Federal and state credits

 

(3.6)

 

(6.5)

 

(5.9)

Permanent items - goodwill impairment

456.3

Permanent items - other

13.2

(6.6)

5.7

Foreign rate differential

19.7

11.8

(5.9)

Other

 

1.7

 

(10.6)

 

9.7

Valuation allowance

 

615.2

 

24.2

 

(30.1)

Income tax expense (benefit)

$

59.9

$

(22.5)

$

13.6

Effective income tax rate

 

(1.3)

%  

 

13.1

%  

 

11.0

%

Schedule of significant components of deferred income tax assets and liabilities

December 31, 2020

December 31, 2019

 

Deferred Income Tax

Deferred Income Tax

 

(In millions)

    

Assets

    

Liabilities

    

Assets

    

Liabilities

 

Tangible assets

    

$

    

$

(179.7)

    

$

    

$

(152.6)

Right-of-use assets

(1,043.1)

(1,187.2)

Accrued liabilities

 

24.2

 

 

17.0

 

Intangible assets

 

 

(105.0)

 

 

(99.7)

Receivables

 

8.5

 

 

7.8

 

Investments

 

55.7

 

 

17.8

 

Capital loss carryforwards

 

1.2

 

 

1.2

 

Pension and deferred compensation

 

15.4

 

 

21.6

 

Corporate borrowings

 

42.0

 

 

 

(101.8)

Disallowed interest

32.3

42.1

Deferred revenue

 

193.3

 

 

170.8

 

Lease liabilities

 

1,294.3

 

 

1,377.7

 

Finance lease obligations

 

1.6

 

 

2.4

 

Other credit carryovers

 

19.6

 

 

18.0

 

Other comprehensive income

 

 

(1.1)

 

 

(1.0)

Net operating loss carryforwards

 

365.5

 

 

202.8

 

Total

$

2,053.6

$

(1,328.9)

$

1,879.2

$

(1,542.3)

Less: Valuation allowance

 

(764.9)

 

 

(312.8)

 

Net deferred income taxes

$

1,288.7

$

(1,328.9)

$

1,566.4

$

(1,542.3)

Schedule of rollforward of the Company's valuation allowance for deferred tax assets

Additions

Charged

Balance at

Charged

Charged

(Credited)

Beginning of

(Credited) to

(Credited) to

to Other

Balance at

(In millions)

    

Period

    

Expenses(1)

    

Goodwill

    

Accounts(2)

    

End of Period

Calendar Year 2020

Valuation allowance-deferred income tax assets

$

312.8

615.2

(163.1)

$

764.9

Calendar Year 2019

Valuation allowance-deferred income tax assets

$

323.6

24.2

(35.0)

$

312.8

Calendar Year 2018

Valuation allowance-deferred income tax assets

$

338.4

(30.1)

15.3

$

323.6

(1)The 2020 valuation allowance primarily relates to the Company’s increase in the current year’s federal, state and international net operating losses, for which no benefit has been recognized, and the establishment of a valuation allowance to reduce the previously recognized benefit of deferred tax assets in Germany and Spain, which an expense of $73.2 million has been recognized.
(2)Primarily relates to amounts resulting from the Company’s changes in deferred tax assets and associated valuation allowance that are not related to income statement activity as well as amounts charged to other comprehensive income. In 2019, this includes $(28.6) million of valuation allowance associated with the sale of the Austria theatres.
Schedule of reconciliation of the change in the amount of unrecognized tax benefits

Year Ended

(In millions)

    

December 31, 2020

    

December 31, 2019

    

December 31, 2018

Balance at beginning of period

$

31.0

$

22.0

$

15.3

Gross increases—current period tax positions

 

4.8

 

10.5

 

7.3

Gross decreases—prior period tax positions

(1.3)

(1.5)

(0.6)

Gross decreases—expiration of statute of limitations

(1.0)

Balance at end of period

$

33.5

$

31.0

$

22.0